SUPPLEMENT

FY2026 — Additional analyst information

FY2026PDF · 18 pages580 KB
This pack has been prepared to aid discussion and provide further
supplementary information only and has not been subject to an
external review or audit
# Public

-- 1 of 18 --

CUSTOMERS PER ENTITY
Life Policyholders
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 465,203 459,473 453,418 450,866 449,211 449,300 447,690 449,130 449,020 449,378 448,313 445,813 446,713 452,561 446,475
Invest
Invest - DRO 136,969 137,008 137,297 137,441 137,503 137,718 137,189 135,819 134,721 133,741 132,817 131,244 129,606 127,831 124,135
Invest - Other 260,765 251,084 241,608 236,055 229,871 225,414 221,273 216,479 212,161 206,778 201,210 195,231 192,615 189,210 185,025
Umbrella (lives) 121,945 114,848 101,448 98,188 92,178
Umbrella schemes 569 548 511 503 480
HealthyCompany 183,995
Group (lives) 697,760 652,168 702,521 707,154 711,051 707,756 711,161 680,754 584,081 562,769 576,450 562,440 578,035 551,219 544,443
Group schemes 2,550 2,531 2,548 2,581 2,616 2,647 2,663 2,666 2,793 2,844 2,827 2,825 2,797 2,740 2,771
Life NB API
12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to
R million June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 2,811 1,441 2,733 1,441 2,778 1,444 2,663 1,355 2,362 1,204 2,072 1,068 2,126 1,165 2,215
Group 137 67 87 23 164 75 175 130 181 64 193 94 160 75 97
Umbrella 278 128 383 192 626
HealthyCompany 18
Invest - Recurring 1,886 977 1,624 867 1,673 851 1,551 796 1,428 737 1,167 573 1,164 686 1,221
Invest - Single API1 1,979 983 1,806 867 1,627 778 1,500 708 1,493 782 1,570 744 1,508 671 1,382
Total Life API 7,109 3,596 6,633 3,390 6,868 3,148 5,889 2,989 5,463 2,786 5,001 2,478 4,958 2,597 4,915
1 API shown at 10% of Single premium
Health Members
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
DHMS - Keycare 170,122 186,366 189,775 204,847 207,934 226,848 225,517 232,988 232,055 234,421 235,841 230,960 232,714 243,046 240,140
DHMS - Non-Keycare 1,212,062 1,182,021 1,169,413 1,154,532 1,152,395 1,147,016 1,149,861 1,142,556 1,135,853 1,118,591 1,111,545 1,099,553 1,111,079 1,108,674 1,110,401
In-House Schemes 373,811 366,017 370,608 356,504 354,944 321,333 319,813 321,838 318,246 316,973 321,613 321,767 319,974 317,408 316,410
Total 1,755,995 1,734,404 1,729,796 1,715,883 1,715,273 1,695,197 1,695,191 1,697,382 1,686,154 1,669,985 1,668,999 1,652,280 1,663,767 1,669,128 1,666,951
Health Lives
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
DHMS - Keycare 278,196 308,665 315,406 343,648 350,038 385,906 384,759 398,397 397,595 401,307 404,984 400,108 403,392 420,869 415,436
DHMS - Non-Keycare 2,457,073 2,416,457 2,401,304 2,391,556 2,394,452 2,402,336 2,413,851 2,412,595 2,406,528 2,383,486 2,375,082 2,358,232 2,381,735 2,387,237 2,394,336
In-House Schemes 840,694 824,525 813,719 800,093 798,933 710,485 707,406 710,427 704,472 699,342 707,293 704,749 698,534 689,688 686,114
Total 3,575,963 3,549,647 3,530,429 3,535,297 3,543,423 3,498,727 3,506,016 3,521,419 3,508,595 3,484,135 3,487,359 3,463,089 3,483,661 3,497,794 3,495,886
Vitality SA
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 20222 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Total Vitality Health,
Vitality Drive and Vitality
Money programme lives
3,463,461 3,306,992 3,157,572 3,038,785 2,922,347 2,822,972 2,652,877 2,498,048 2,348,834 2,242,401 2,163,411 2,122,453 2,065,868 2,060,011 1,987,237
2 restated to include for LA wellness figures
VitalityHealth Members
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 143,023 141,965 141,822 141,014 140,400 138,278 135,117 129,568 124,395 117,007 113,189 108,955 105,915 104,997 101,702
SME 347,961 347,827 349,465 344,320 340,983 327,876 310,624 285,865 263,216 238,540 222,961 211,949 212,305 209,509 201,960
Corporate 141,479 136,345 131,885 128,241 120,685 112,941 108,191 102,823 99,578 89,881 86,149 80,514 81,124 78,050 70,583
Trust and Cost Plus 20,352 19,668 18,496 20,198 20,237 16,448 16,339 14,511 8,698 3,944 2,731 2,639 - - -
Lite 1,034 80 - - - - - - - - - - - - -
Total 653,849 645,885 641,668 633,773 622,305 595,543 570,271 532,767 495,887 449,372 425,030 404,057 399,344 392,556 374,245
VitalityHealth Lives
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Individual 269,634 265,301 262,888 261,481 260,210 256,527 250,551 238,629 227,684 212,896 204,890 195,996 188,976 186,559 179,811
SME 546,885 547,180 550,925 545,424 541,111 522,753 496,299 460,442 429,110 395,777 374,179 357,768 356,907 353,763 342,431
Corporate 222,826 217,226 210,225 202,151 191,015 178,163 171,364 163,120 158,890 148,654 143,905 135,218 135,440 131,991 120,157
Trust and Cost Plus 35,841 34,671 32,739 35,214 35,163 27,349 26,854 22,673 15,903 6,509 4,066 3,956 - - -
Lite 1,250 99 - - - - - - - - - - - - -
Total 1,076,436 1,064,477 1,056,777 1,044,270 1,027,499 984,792 945,068 884,864 831,587 763,836 727,040 692,938 681,323 672,313 642,399
VitalityLife Policies
June 2026 December 2025 June 2025 December 20243 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Policies 890,028 837,243 781,548 723,213 679,382 646,564 622,451 593,322 565,778 535,281 517,913 493,970 474,890 458,675 434,678
3 December 2024 has been restated
VitalityLife Lives
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Lives4 1,006,514 957,864 903,996 852,154 810,050 782,296 764,699 735,137 702,105 669,139 647,020 617,051 594,799 577,965 549,526
4 restated to include unique lives only
Discovery Insure Policies
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Policies 210,103 208,123 208,192 213,762 214,297 215,297 211,223 214,315 213,453 212,570 202,335 191,936 178,517 169,920 159,171
Discovery Bank
June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019
Primary Clients 1,567,789 1,402,626 1,246,817 1,092,386 958,055 825,069 702,131 581,457 470,220 385,177 331,088 287,183 206,810 61,731 1,476
Total Accounts 3,766,907 3,365,688 2,995,078 2,608,023 2,271,703 1,933,839 1,625,912 1,312,970 1,023,790 793,215 648,546 521,081 357,416 141,660 3,740
2 Membership # Public

-- 2 of 18 --

VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE
June 2026
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (585) (3,186) (1,741) (3,915) (9,427)
Value of In Force 2,091 3,741 2,295 4,477 12,604
Cost of Capital (51) (86) (60) (159) (356)
1,455 469 494 403 2,821
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 2,057 2,787 2,078 3,676 10,598
Cost of Capital (50) (86) (56) (145) (337)
2,007 2,701 2,022 3,531 10,261
December 2025
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (286) (1,622) (879) (1,925) (4,712)
Value of In Force 926 1,966 1,161 2,181 6,234
Cost of Capital (23) (43) (29) (71) (166)
617 301 253 185 1,356
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 922 1,475 1,093 1,897 5,387
Cost of Capital (23) (43) (28) (70) (164)
899 1,432 1,065 1,827 5,223
June 2025
VNB at Point of Sale
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Acquisition Costs and Initial strain (537) (2,937) (1,653) (3,622) (8,749)
Value of In Force 1,632 3,472 2,324 3,775 11,203
Cost of Capital (45) (74) (62) (119) (300)
1,050 461 609 34 2,154
New business contribution to value of in force at valuation date
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Value of In Force 1,597 2,449 2,210 3,404 9,660
Cost of Capital (43) (74) (63) (110) (290)
1,554 2,375 2,147 3,294 9,370
3 Value of New Business # Public

-- 3 of 18 --

EV RECONCILIATION TO INCOME STATEMENT
for the year ended 30 June 2026
R million
Embedded
Value
Earnings
Value of In-
Force
Cost of
required
Capital
Impact on
Income
Statement
Adjustment to
Shareholders
Funds
Statement of
Changes in
Equity
Total profit from new business (at point of sale) 2,821 10,411 (356) (7,234) - -
- Health and Vitality 1,455 1,953 (51) (447) - -
- Life 469 2,703 (86) (2,148) - -
- VitalityHealth 494 2,051 (60) (1,497) - -
- VitalityLife 403 3,704 (159) (3,142) - -
Profit from existing business
Expected return 10,947 1,175 (5) 9,777 - -
- Health and Vitality 3,823 282 15 3,526 - -
Expected transfer from VIF to net worth - (3,526) - 3,526 - -
Unwinding of the risk discount rate 3,823 3,808 15 - - -
- Life 4,931 1,637 20 3,274 - -
Expected transfer from VIF to net worth - (3,274) - 3,274 - -
Unwinding of the risk discount rate 4,931 4,911 20 - - -
- VitalityHealth 1,186 (809) (31) 2,026 - -
Expected transfer from VIF to net worth - (2,026) - 2,026 - -
Unwinding of the risk discount rate 1,186 1,217 (31) - - -
- VitalityLife 1,007 65 (9) 951 - -
Expected transfer from VIF to net worth - (951) - 951 - -
Unwinding of the risk discount rate 1,007 1,016 (9) - - -
Change in methodology and assumptions 5,330 2,223 (116) 3,223 - -
- Health and Vitality 669 646 23 - - -
- Life 5,162 4,547 (100) 715 - -
- VitalityHealth (489) (503) 14 - - -
- VitalityLife (12) (2,467) (53) 2,508 - -
Experience variances 3,116 1,198 78 1,840 - -
- Health and Vitality 1,216 717 (16) 515 - -
- Life 1,222 474 9 739 - -
- VitalityHealth 520 (90) 85 525 - -
- VitalityLife 158 97 - 61 - -
Increase in goodwill and intangibles (344) - - - (344) -
Non-covered business 2,819 - - 2,819 - -
Non-recurring expenses (280) - - (280) - -
Acquisition costs (61) 3 - (64) - -
Finance costs (3,018) - - (3,018) - -
Other (74) - - 1 (75) -
Foreign Exchange Rate Movements (4,803) (3,732) 133 1,545 404 (3,153)
Intangibles 404 - - - 404 -
Other (5,207) (3,732) 133 1,545 - (3,153)
Return on shareholders' funds 1,433 - - 1,478 - (45)
Unrealised gain on investments and realised gain on investments
transferred to income statement 1,029 - - 1,074 - (45)
Health and Vitality investment income 105 - - 105 - -
Life investment income 299 - - 299 - -
VitalityHealth investment income - - - - - -
VitalityLife investment income - - - - - -
Amortisation of Intangibles (41) - - (636) 595 -
Amortisation of intangibles from business combinations (41) - - (65) 24 -
Amortisation of systems intangibles - - - (571) 571 -
VitalityHealth and VitalityLife DAC and unemployment reserve - - - (3) 3 -
Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - 1,550 (1,550) -
Life assets under insurance contracts - - - 2,766 (10,611) 7,845
VitalityLife net assets under insurance contracts - - - (544) (28) 572
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset - - - (18) 18 -
VitalityHealth FinRe - - - (53) 53 -
Equity settled share based payment mark-to-market adjustment - - - 69 (69) -
Embedded value earnings 17,845 11,278 (266) 13,218 (11,604) 5,219
Adjustment to Shareholders' Funds:
Change in: *
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 71
Intangibles & Goodwill 583
Life net assets under insurance contracts (10,611)
VitalityLife net assets under insurance contracts (28)
1 DP IFRS 16 financial lease accounting (1,550)
Equity settled share based payment mark-to-market adjustment (69)
* The total change in the net assets under insurance contracts consists of the change in the Negative Rand Reserve (NRR), which is zeroised in the embedded value. The change in the NRR is split
between the Income Statement and the change in the Insurance Finance Reserve, which flows through the Statement of Changes in Equity (SOCIE).
4 EV recon # Public

-- 4 of 18 --

EV BUILD-UP PER ENTITY
for the year ended 30 June 2026
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total
Value of in-force business at 30 June 2025 27,447 41,255 17,869 14,944 - 101,515
Expected return (in-force business) 3,721 4,779 1,093 884 - 10,477
Release of profits (in-force business) (3,526) (3,274) (2,026) (951) - (9,777)
Value of new business 2,040 3,655 2,235 4,318 - 12,248
Expected return (new business) 102 152 93 123 - 470
Release of profits (new business) (138) (1,038) (244) (773) - (2,193)
Experience variances 701 483 (5) 97 - 1,276
Methodology changes 669 4,447 (489) (2,520) - 2,107
Other - 3 (1,946) (1,653) - (3,596)
Value of in-force business at 30 June 2026 31,016 50,462 16,580 14,469 - 112,527
Shareholders’ funds per Balance Sheet 2,069 44,345 10,155 6,919 19,173 82,661
Adjustment to shareholders' funds - (31,944) (5,049) (11,695) (3,576) (52,264)
Embedded value at 30 June 2026 33,085 62,863 21,686 9,693 15,597 142,924
5 EV Buildup per Entity # Public

-- 5 of 18 --

COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO
SHAREHOLDERS' FUNDS ON PUBLISHED BASIS
R million June 2026 June 2025
1. Assets under insurance contracts
Discovery Life positive liabilities not netted off with negative liabilities: 587 571
Discovery Life long term reserves in respect of policies with net negative liabilities: (46,786) (31,656)
Working capital 211 210
Discovery Life liability for incurred claims (LIC) 8,294 7,873
Total Assets under insurance contracts: (37,694) (23,002)
2. Negative liabilites not included under assets under insurance contracts
Negative reserve in respect of Invest business (8,044) (7,617)
DAC and DRL in respect of Invest business (905) (811)
(8,949) (8,428)
3. Components to be zeroised based on the Method of Distributable Cashflows:
Discovery Life long term reserves in respect of policies with net negative liabilities: (46,786) (31,656)
Liabilities under reinsurance contracts* 1,090 432
Negative reserve in respect of Invest business (8,044) (7,617)
DAC and DRL in respect of Invest business (905) (811)
Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 11,220 6,705
Liabilities off set against Negative reserve before zeroisation 11,481 11,614
(31,944) (21,333)
* This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the
method of distributable cashflows.
4. Other adjustments to published Shareholders' funds
VitalityLife net assets under insurance contracts (11,691) (11,663)
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset (5,049) (5,120)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (4) (7)
Goodwill (2,689) (3,012)
Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance
Company joint venture (556) (813)
Net preference share capital (779) (779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting - 1,550
Equity settled share based payment mark-to-market adjustment 448 517
Adjustment to Shareholders' funds from published basis (52,264) (40,660)
The "Reversal of 1 Discovery Place IFRS 16 financial lease accounting" adjustment has reduced from R1.55 billion at 30 June 2025 to nil at 30 June 2026 following the
purchase of the 1 Discovery Place building. The historical EV adjustment is no longer required and has been replaced by a once-off gain of R1.07 billion (net of tax)
recognised on the termination of the lease arrangement, which is reflected in the Shareholders' funds and therefore forms part of the Adjusted net worth.
6 EV Adjustment to SH funds # Public

-- 6 of 18 --

RECONCILIATION TO THE REQUIRED CAPITAL
for the year ended 30 June 2026
R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total
Opening - 30 June 2025 1,286 29,349 4,761 13,050 48,446
- Methodology and Basis Changes - 5,826 - 612 6,438
- Expected release on in-force at start of period (34) (668) (155) (584) (1,441)
- Impact of new business written 136 1,105 504 2,278 4,023
- Other changes* (60) 1,827 (329) - 1,438
- Exchange rate movements - - (512) (1,540) (2,052)
Change in Required Capital 42 8,090 (492) 766 8,406
Closing - 30 June 2026 1,328 37,439 4,269 13,816 56,852
*This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required capital. This component
of the expected yield curve unwind is shown separately from the expected release for information purposes only.
7 Recon of Required Capital # Public

-- 7 of 18 --

BREAKDOWN OF INVEST AND UMBRELLA ASSETS UNDER ADMINISTRATION
R million Invest Umbrella
December 2021 127,632
June 2022 121,737
December 2022 130,830
June 2023 140,378
December 2023 144,810
June 2024 154,653 17,074
December 2024 166,915 18,196
June 2025 178,744 22,487
December 2025 199,820 25,436
June 2026 204,543 26,472
8 Invest and Umbrella AUA # Public

-- 8 of 18 --

SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS
R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL
30 June 2026
Income statement
Insurance revenue 803 19,601 4,796 6,448 - 20,611 9,184 (1) 61,442 - 61,442
- Contracts measured under the General measurement model/Variable fee approach - 15,847 4,796 - - - 9,184 - 29,827 - 29,827
- Contracts measured under Premium allocation approach 803 3,754 - 6,448 - 20,611 - (1) 31,615 - 31,615
Insurance service expenses (556) (16,059) (3,086) (5,588) - (18,046) (8,250) 8 (51,577) - (51,577)
- Claims and benefits (378) (11,576) (702) (2,923) - (11,545) (3,687) 10 (30,801) - (30,801)
- Insurance service expense and other (109) (1,987) (1,432) (1,672) - (4,328) (1,136) (2) (10,666) - (10,666)
- Insurance acquisition cash flows (69) (2,496) (952) (993) - (2,173) (3,427) - (10,110) - (10,110)
Tax specific to policyholder tax funds - - (116) - - - - - (116) 116 -
Insurance service result (pre-reinsurance) 247 3,542 1,594 860 - 2,565 934 7 9,749 116 9,865
Net expenses from reinsurance contracts (2) (606) - (117) - 2 (395) (6) (1,124) - (1,124)
- Reinsurance expense (3) (3,971) - (117) - (4) (9,303) - (13,398) - (13,398)
- Insurance claims recovered from reinsurers 1 3,365 - - - 6 8,908 (6) 12,274 - 12,274
Insurance service result 245 2,936 1,594 743 - 2,567 539 1 8,625 116 8,741
Net financial result from insurance finance income and expense - 2,766 (16,194) (20) - - 244 - (13,204) (91) (13,295)
- Net finance income/(expense) from insurance contracts - 2,825 (16,194) (19) - - 648 - (12,740) (91) (12,831)
- Net finance expense from reinsurance contracts - (59) - (1) - - (404) - (464) - (464)
Investment income using the effective interest rate method 11 84 103 322 - 203 79 27 829 288 1,117
Net fair value gains on financial instruments at fair value through profit or loss 2 3,303 17,497 2 59 42 - - 20,905 5,234 26,139
Fair value adjustments to liabilities under investment contracts - (2,810) (1,159) - - - - - (3,969) 75 (3,894)
Third party interest: fair value adjustments to liabilities under investment contracts - - - - - - - - - (4,317) (4,317)
Net insurance and investment results 258 6,279 1,841 1,047 59 2,812 862 28 13,186 1,305 14,491
Fee income from administration businesses 10,341 228 1,605 - - 38 - 2,492 14,704 (105) 14,599
Vitality income - - - - - 31 298 5,880 6,209 (590) 5,619
Net banking fee and commission income - - - - 1,815 - - (91) 1,724 375 2,099
- Banking fee and commission income - - - - 2,763 - - - 2,763 (14) 2,749
- Banking fee and commission expense - - - - (948) - - (91) (1,039) 389 (650)
Net banking interest and similar income - - - - 1,255 - - - 1,255 1 1,256
- Banking interest and similar income using the effective interest rate - - - - 2,570 - - - 2,570 - 2,570
- Banking interest and similar expense using the effective interest rate - - - - (1,315) - - - (1,315) 1 (1,314)
Other income 2,054 193 1 77 58 - - 16,062 18,445 (14,635) 3,810
Non-insurance revenue and income 12,395 421 1,606 77 3,128 69 298 24,343 42,337 (14,954) 27,383
Net income 12,653 6,700 3,447 1,124 3,187 2,881 1,160 24,371 55,523 (13,649) 41,874
Non-insurance acquisition costs - - (503) - - - - (197) (700) 364 (336)
Expected credit losses - - - - (350) - - - (350) - (350)
Marketing and administration expenses (8,023) (828) (787) (169) (2,467) (985) (377) (24,690) (38,326) 15,751 (22,575)
Share of net profits from equity-accounted investments (1) - - 58 - - (1) 1,547 1,603 (80) 1,523
Normalised profit/(loss) from operations 4,629 5,872 2,157 1,013 370 1,896 782 1,031 17,750 2,386 20,136
Investment income earned on shareholder investments and cash 104 - 4 12 - - 2 166 288 (288) -
Intercompany investment income - - - - - - - 1,367 1,367 (1,367) -
Net fair value gains on financial assets at fair value through profit or loss - 178 48 - - - - 89 315 (315) -
Gain from dilution of equity accounted investments - - - 211 - - - - 211 50 261
Amortisation of intangibles from business combinations - - - (30) - - - (85) (115) 115 -
Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - (33) (33) 33 -
1DP Lease termination gains - - - - - - - 1,463 1,463 (1,463) -
Restructuring costs - - - - - - - (1) (1) 1 -
Interest expenses on borrowings and lease liabilities (3) (1) - - - (24) (65) (1,396) (1,489) (328) (1,817)
Intercompany finance expenses on borrowings (460) - - - - - (463) (444) (1,367) 1,367 -
Foreign exchange losses - - - - - - - (123) (123) - (123)
Profit/(loss) before income tax 4,270 6,049 2,209 1,206 370 1,872 256 2,034 18,266 191 18,457
Income tax expense (1,138) (1,615) (1,074) (257) (152) (469) (97) (246) (5,048) (191) (5,239)
Profit/(loss) for the year 3,132 4,434 1,135 949 218 1,403 159 1,788 13,218 - 13,218
Profit attributable to:
Ordinary shareholders 3,132 4,434 1,135 949 218 1,403 159 1,702 13,132 - 13,132
Preference shareholders - - - - - - - 86 86 - 86
Non-controlling interest - - - - - - - - - - -
Segment information
IFRS REPORTING
ADJUSTMENTS
# Public

-- 9 of 18 --

VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST
R million June 2026 December 2025 June 2025 December 2024 June 2024
VIF1
Life 35,749 32,654 27,910 27,082 24,138
Invest 14,713 15,194 13,346 12,715 11,675
APE2
Life 803 411 735 355 804
Invest 2,901 1,467 2,535 1,234 2,411
VNB1
Life 241 138 113 94 225
Invest 228 163 349 145 256
2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium
Investment business) in relation to New Business only, and excludes any addition to Existing Business
premiums arising from servicing increases and ACIs.
Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for
December 2016 and later periods.
1 These VIF and VNB numbers are after allowing for the Cost of required Capital.
10 Results split Life and Invest # Public

-- 10 of 18 --

Group Shareholder Free Cash Movement
R millions FY2026 H1 FY2026 FY2025 H1 FY2025 FY2024
Cash Generated from In-Force Before Financing and Tax 21,438 9,652 17,655 8,319 14,617
New Business Net of External Financing (7,318) (3,679) (6,791) (3,506) (6,823)
Tax Paid (2,825) (1,337) (1,867) (758) (1,522)
Operating Cash Flow 11,295 4,636 8,997 4,055 6,272
New Initiatives (76) 51 (843) (727) (1,025)
Business Development and Other (1,148) (609) (1,016) (595) (1,580)
Finance Cost Paid (1,568) (823) (1,691) (899) (1,566)
Dividends Paid (2,205) (1,407) (1,708) (1,073) (1,270)
Financing and Matching Initiatives (1,398) (722) (539) (236) (496)
Transactions with Debt Holders (Excl. Finance Costs) (2,058) (182) (1,572) (491) 1,130
1 Discovery Place Transaction (1) (6) - - - -
Purchase of Property (4,053) - - - -
Debt Funding 4,047 - - - -
Once-offs (2) 801 - - - -
Movement in Shareholder Free Cash 3,637 944 1,629 35 1,465
Remove ordinary dividends paid in period 2,119 1,361 1,614 1,026 1,179
Add ordinary dividends payable in respect of period (2,621) (758) (1,949) (588) (1,465)
Movement in Shareholder Free Cash – Dividend Accrual Basis (3) 3,135 1,547 1,294 473 1,179
Movement in Shareholder Free Cash - Excl Transactions with Borrowers and Financing
and Matching Initiatives 9,299 3,255 5,448 1,835 2,101
Operating Cash Flow 11,295 4,636 8,997 4,055 6,272
IFRS Normalised Profit from Operations net of Tax Expense (4) 13,226 6,508 11,277 5,269 9,170
Cash Conversion Ratio (4) 85% 71% 80% 77% 68%
Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period
R millions FY2026 H1 FY2026 FY2025 H1 FY2025 FY2024
Profit for the period 13,218 5,759 9,559 4,329 7,549
Reverse non-cash profit items:
Share of net (profits)/losses from equity accounted investments (1,603) (732) (1,266) (425) (1,031)
Losses/(gains) from dilution of equity accounted investments (211) - 32 26 (22)
Depreciation and amortisation 2,313 1,127 2,177 1,074 2,160
Impairment of intangible assets 69 28 131 21 45
Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) - - - - -
Movement in contract assets (173) (252) (359) (462) (640)
Amortisation of intangibles from business combinations - - - - -
Non cash impact of Vitality Health DAC (500) (219) (510) (217) (411)
Non-cash fair value gains on financial assets (315) (125) (21) (47) (87)
Non-cash forex gains / losses - - 20 - 0
Bank interest income incurred to cash (362) (137) (152) (277) -
Gains or losses on lease modification (1,463) - - - -
Other non-cash adjustments to profit 18 (89) 57 (22) (151)
Adjustments from IFRS to EV ANW:
Increase in Negative Reserves and Invest DAC (Net of tax) (2,222) (1,186) (3,181) (1,487) (4,733)
Exchange rate movements on Vitality Life Negative Reserves (975) (774) 481 206 (385)
Other adjustments to arrive at EV ANW 1,002 59 (279) 404 1,644
Incurred to Cash basis:
Rent Paid (627) (303) (580) (329) (511)
Finance Costs Paid (2,678) (1,350) (2,877) (1,494) (2,603)
Finance Costs Accrued 3,395 1,724 3,324 1,711 3,097
Taxation paid (2,825) (1,337) (1,867) (758) (1,522)
Taxation Accrued 2,826 1,221 2,049 654 1,093
Investing Activities:
Purchase of property and equipment (4,533) (145) (294) (120) (414)
Proceeds from disposal of property and equipment 2 2 3 3 28
Purchase of intangible assets (1,510) (735) (1,682) (875) (1,789)
Proceeds from disposal of intangible assets 2 - - 0 -
Increase in investment in associate 467 (0) (316) 0 (0)
Increase in investment & dividends from equity accounted investment 539 (3) 463 (11) 287
Cash proceeds from CMT transaction - - - (304) -
Financing Activities:
Increase in borrowings 13,049 2,592 3,264 1,765 2,005
Repayment of borrowings (11,061) (2,774) (4,836) (2,257) (874)
Dividends paid to ordinary shareholders (2,119) (1,363) (1,614) (1,026) (1,179)
Dividends paid to preference shareholders (86) (44) (93) (47) (91)
Share Issue (Net of Share Issue Costs) - - - - -
Movement in Shareholder Free Cash 3,637 944 1,629 35 1,465
Notes
"Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in
working capital are not allowed for in the estimate.
1) The impact on shareholder free cash from the “1 Discovery Place Transaction” is neutral, as the purchase of the property was fully funded with debt. The debt funding for the “1 Discovery Place Transaction” should
be considered with the disclosed “Transactions with Debt Holders (Excl. Finance Costs)” line to represent total debt holder transactions for the Group from a shareholder free cash perspective.
2) The once-offs relate to CMT sale proceeds.
3) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For the year ended 30 June 2026, the interim declared dividend of
R756m, per the interim financial results, and the final declared dividend of R1 863m, per the annual financial results, are used as the total dividend accrued in respect of the twelve-month period.
4) Cash conversion is calculated as Operating Cash Flow per the Group shareholder free cash movement, divided by Normalised Profit from Operations (IFRS total, excluding the IFRS Reporting Adjustments for
shareholder investment income and fair value gains/(losses)) net of Income tax expense (IFRS total) per A.1 Segment Information. For June 2026, Normalised Profit from Operations has been further adjusted to exclude
the once-off net-of-tax gain arising on the 1DP lease termination, resulting in a more representative measure of underlying cash conversion.
# Internal

-- 11 of 18 --

Reconciliation of operating profit to normalised operating profit
for the year ended 30 June 2026
Group Group
R million
Year
ended
June 2026
Year
ended
June 2025 % change
Operating profit 18,613 14,587 28%
Share of net profits from equity accounted investments 1,523 1 215
Impairment of goodwill - 20
Normalised profit from operations per Segment information (IFRS total) 20,136 15,822 27%
Normalised profit adjustments (2 386) ( 612)
Investment income earned on shareholder investments and cash ( 288) ( 352)
Difference between market related rental and depreciation and finance costs (Head office) ( 230) ( 205)
Tax specific to policyholder tax funds ( 191) ( 152)
Net fair value gains on financial assets at fair value through profit or loss ( 315) ( 105)
Amortisation of intangibles from business combinations 115 122
Restructuring costs ( 1) 80
CMT disposal costs 50 -
1DP lease termination (1 526) -
Normalised profit from operations 17,750 15,210 17%
12 Op Profit recon # Public

-- 12 of 18 --

Discovery Bank additional performance metrics
for the six months ended 30 June 2026
2026 H2 2026 H1 2025 H2 2025 H1 2024 H2 2024 H1 2023 H2 2023 H1
Profitability and Efficiency
Retail Net Interest Margin (NIM)* 8.30% 8.35% 8.85% 9.65% 10.19% 10.06% 9.53% 9.37%
Asset Quality
Non-Performing Loan (NPL) Ratio 4.82% 4.76% 4.79% 4.92% 5.41% 5.84% 5.02% 4.16%
Capital Adequacy
Common Equity Tier 1 (CET1) Ratio 17.00% 15.19% 16.31% 16.67% 17.63% 17.07% 16.82% 16.47%
Liquidity
Loan-to-Deposit Ratio (LDR) 47.39% 42.96% 39.37% 37.05% 35.72% 34.48% 36.08% 23.46%
*Excludes interest on bonds
# Public

-- 13 of 18 --

NAV PER ENTITY
for the year ended June 2026
Covered businesses June 2026
NAV before adjustment to shareholder funds
Health and Vitality 2,069
Life and Invest 44,345
VitalityHealth 10,155
VitalityLife 6,919
Non-covered businesses
Bank, including DCS intangible asset and goodwill 9,289
Insure 2,932
PAHI 8,155
CMT 621
Limited (7,067)
Other 5,243
Total NAV 82,661
# Public

-- 14 of 18 --

Normalised Return on Equity
FY2026 FY2025 FY2024
EARNINGS
Net profit - attributable to: 13,218 9,558 7,549
- Ordinary shareholders 13,132 9,471 7,468 A
- Preference shareholders 86 93 91
- Non-controlling interest - (6) (10)
Earnings adjustments for ordinary shareholders (1,337) 310 43 C=B-A
Normalised headline earnings 11,795 9,781 7,511 B
EQUITY
Opening total equity 65,699 54,451 47,242
- Insurance Finance Reserve (2,928) (4,832) (6,312)
- Perpetual preference share capital 779 779 779
- Non-controlling interest (5) - 4
- Other equity 67,853 58,504 52,771 D
Adjusted opening equity 67,853 58,504 52,771 E=D
Closing total equity 82,661 65,699 54,451
- Insurance Finance Reserve 5,489 (2,928) (4,832)
- Perpetual preference share capital 779 779 779
- Non-controlling interest (7) (5) -
- Other equity 76,400 67,853 58,504 F
Adjusted closing equity 76,400 67,853 58,504 G=F
Normalised adjusted closing equity 75,063 68,163 58,547 H=G+C
Average normalised equity 71,458 63,334 55,659 I=(H+E)/2
RETURN ON EQUITY Full-year
Normalised return on equity (annualised) 16.5% 15.4% 13.5% =B/I
# Public

-- 15 of 18 --

RECONCILIATION OF KEY IFRS 17 METRICS TO EV
for the year ended 30 June 2026
SA Life & Invest
Segment UK Life Segment
Twelve months ended 30 June 2026
IFRS 17 CSM plus Risk Adjustment balance - Gross of tax 44,976 9,194
Reconciling items:
IFRS 17 LRC and LIC net of backing assets1 41,510 10,841
Adjust for tax2 (23,119) (1,999)
Change to Risk Discount Rate (17,007) (2,990)
Limit to EV Term (877) -
VIF on investment contracts measured under IFRS 9 4,673 -
Other IFRS and VIF methodology differences3 2,076 200
Cost of Capital (1,771) (776)
Net value of in-force of covered business (after cost of capital) 50,462 14,469
SA Life & Invest
Segment UK Life Segment
IFRS 17 new business value - Gross of tax 2,677 1,413
Reconciling items:
Adjust for tax2 (835) (520)
Change to Risk Discount Rate (685) (484)
Limit to EV Term (51) -
VNB on investment contracts measured under IFRS 9 55 -
Other IFRS and VNB methodology differences4 (606) 153
Cost of Capital (86) (159)
Net value of new business of covered business (after cost of capital) 469 403
4) Methodology differences in the contract boundary applied to new business as well as differences in economic and non-economic
assumptions. For UK Life, this also includes the exclusion of the impact of new reinsurance contracts attaching to the in-force book in the
year, which is considered part of the opening initial recognition value, but not included in the VNB.
The following table reconciles the IFRS 17 CSM plus Risk Adjustment balances for the SA Life GMM, SA Life PAA, SA Invest GMM, SA Invest VFA
and UK Life GMM portfolios to their Value of In-Force net of Cost of Capital:
1) This item adds back the Liability for Remaining Coverage and the Liability for Incurred Claims to derive the total IFRS 17 BEL, and then
removes the portion of the BEL backed by tangible assets.
2) EV is calculated on a net of tax basis. Tax calculations cover different insurance tax funds, tax credits and IFRS 17 transitional tax
arrangements.
3) This item includes the Group Life VIF & the EV impact of other risk mitigating PAA contracts, and reflects the cost of internal asset-
liability matching structures within the EV basis.
The following table reconciles the IFRS 17 new business value, i.e., the initial recognition values for the SA Life GMM, SA Invest GMM, SA
Invest VFA and UK Life GMM portfolios, to the Value of New Business net of Cost of Capital.
# Public

-- 16 of 18 --

# Public

-- 17 of 18 --

# Public

-- 18 of 18 --